Edition:
United Kingdom

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

1.80USD
13 Dec 2017
Change (% chg)

$0.01 (+0.56%)
Prev Close
$1.79
Open
$1.77
Day's High
$1.83
Day's Low
$1.74
Volume
31,714
Avg. Vol
87,151
52-wk High
$13.24
52-wk Low
$1.20

Latest Key Developments (Source: Significant Developments)

HTG Molecular Diagnostics reports third quarter earnings
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports 2017 third quarter earnings.Q3 loss per share $0.46.Sees FY 2017 revenue $10 million to $13 million.Q3 revenue $3.7 million.  Full Article

HTG Molecular Diagnostics Q2 loss per share $0.98
Tuesday, 9 Aug 2016 

Htg Molecular Diagnostics Inc : Q2 loss per share $0.98 . Htg molecular diagnostics reports second quarter 2016 results .Q2 revenue rose 140 percent to $1.9 million.  Full Article

HTG Molecular, Firalis to develop tool to predict response to anti-TNF-alpha therapies
Wednesday, 6 Jul 2016 

HTG Molecular Diagnostics Inc : HTG Molecular Diagnostics and Firalis announce agreement to develop a theranostic tool to predict response to anti-TNF-alpha therapies for rheumatoid arthritis .Will supply instrumentation and reagents to support Firalis' development, validation, and clinical deployment of Rabiopred.  Full Article

HTG Molecular Diagnostics reports Q1 loss per share $1.02
Thursday, 12 May 2016 

Htg Molecular Diagnostics Inc : Htg molecular diagnostics reports first quarter 2016 results . Q1 loss per share $1.02 .Q1 revenue $900,000.  Full Article

HTG Molecular diagnostics announces Immuno-oncology research collaboration agreement with Bristol-Myers Squibb
Thursday, 12 May 2016 

Htg Molecular Diagnostics Inc : Htg will provide bristol-myers squibb access to its ngs-based htg edgeseq system . Companies will collaborate to develop tools for use for molecular profiling research for immuno-oncology .Htg molecular diagnostics announces immuno-oncology research collaboration agreement with bristol-myers squibb.  Full Article

HTG Molecular Diagnostics, Inc says distribution agreements with Gamidor in Israel and Durviz in Spain and Portugal
Monday, 11 Apr 2016 

HTG Molecular Diagnostics, Inc:Says distribution agreements with Gamidor Diagnostics in Israel and Durviz s.l. Parque Tecnológico de Valencia in Spain and Portugal to manage distribution of HTG's next generation sequencing (NGS)-based products.  Full Article